Amneal Pharmaceuticals’ price target remains steady at $13.50, reflecting ongoing confidence in its consensus valuation despite recent market shifts. Analysts’ latest revisions stem from upbeat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback